BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:S-4321 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of S-4321\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07455578-110@assetmemo.bio
DTSTAMP:20261121T005652Z
DTSTART;VALUE=DATE:20270930
DTEND;VALUE=DATE:20271001
SUMMARY:S-4321: Phase 1 readout est. (NCT07455578)
DESCRIPTION:S-4321\, phase 1\, Psoriatic Arthritis.\nStudy: Study of S-4321
  in Participants With an Autoimmune or Immune-mediated Disease\nEstimated 
 primary completion: September 2027. This is a ClinicalTrials.gov estimate\
 , not a confirmed readout date\, and it can move.\nDrug page: https://asse
 tmemo.bio/drug/s-4321#upcoming-events\nRegistry record: https://clinicaltr
 ials.gov/study/NCT07455578
URL:https://assetmemo.bio/drug/s-4321#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
